Article
Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced…
medRxiv · 2023 · Andrew J. Flores
Key facts
| Title | Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion |
|---|---|
| First author | Andrew J. Flores |
| Journal | medRxiv |
| Published | Sep 26, 2023 |
| DOI | 10.1101/2023.07.31.551112 |
| Devices mentioned | K120877 |
| Product codes mentioned | KWP, NKG, LXC, MQJ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1